PowerHome is a manufacturer and global supplier of power conversion equipment, specializing in single-phase and three-phase ...
Researchers at Skoltech have developed an ultra-compact electro-optic modulator based on silicon photonics and plasmonics ...
Confirmed RECIST v1.1 ORR favored varegacestat (56% vs 9%; P<.0001), with exploratory median best tumor-volume change of −83% ...
The Phase 1/2 FUNCTION-DMD study will enroll ambulatory patients and is designed to evaluate safety, tolerability, and efficacy, including dystrophin protein expression and functional outcomes. "The ...
Energenesis Biomedical Co., Ltd. (TWSE: 6657), a clinical-stage biopharmaceutical company focused on cellular energy restoration therapeutic ...
EPC’s evaluation kit for a three-phase inverter platform based on its Gen-7 EPC2366 eGaN power transistor streamlines motor ...
Researchers led by Professor Ting Mei (Northwestern Polytechnical University) and Professors Xiaocong Yuan & Yuquan Zhang ...
Energenesis Biomedical Co., Ltd. (TWSE: 6657), a clinical-stage biopharmaceutical company focused on cellular energy restoration therapeutics, today announced ...
A rolling NDA has been initiated for tinlarebant in STGD1, potentially positioning the first disease-modifying systemic ...
Sweet proteins such as brazzein add an exciting new dimension to the sugar-reduction toolbox, claims Pentasweet.
Ultrasome™ Demonstrates Strong Clinical Signal While Leveraging GMP-Produced CELZ-201 (Olastrocel) to Target Large, Underserved Osteoarthritis ...
Tovecimig (a DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel demonstrated a highly statistically significant improvement versus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results